| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222882 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Erlotinib and radiation therapy had an acceptable toxicity profile in patients with advanced cutaneous squamous cell carcinoma. The disease-free survival in this cohort was comparable to that in historical controls.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
C. Hope MD, MS, Nicholas L. BS, Lisle MD, William R. MD, Renee PhD, DVM, Lisa RN, Sharon MD, J. Scott MD, Eben L. MD,